US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Cannabis Concept

246.51

+1.150.47%

Number of Gainers:2

Number of Losers:13

Number of Flat:1

PE:- -

High:248.13

Open:245.35

Low:241.34

Close:245.37

Volume:22.42M

Turnover:374.86M

Market Cap:60.73B

Float Cap:53.63B

Loading ...

Shock Top and Auntie Anne’s® Take Over Tailgate Season with the Return of Shock Top Twisted Pretzel Wheat and the Limited-Edition TWIST Vest

Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes

Table: Aurora Corp Aug Rev Nt$950.6m vs Nt$917.5m

AIM ImmunoTech Advances Phase 2 Duripanc Trial of Ampligen Plus AstraZeneca’s Imfinzi in Pancreatic Cancer

Leerink Partners Initiates Coverage on Harrow With Outperform Rating, $45 Price Target

MT Newswires Live

Press Release: Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business

Press Release: Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business

Broncos Country, This One’s for You: Breckenridge Distillery Kicks Off Another Season with the Denver Broncos and a Limited-Edition Whiskey Collection Honoring “The Drive”

Dr. Reddy's Laboratories Slides Wednesday, Still Outperforms Market

Teva initiated with an Outperform at Leerink

Harrow initiated with an Outperform at Leerink

SNDL Sets October 15 Virtual Meeting and Seeks Approval for Share Consolidation

SNDL Sets Virtual Annual and Special Shareholder Meeting, Share Consolidation Vote on Agenda

SNDL Announces Annual and Special Shareholder Meeting

Cannabis Poland Raises Capital Through New Share Issue and Warrant Allocation to CPAR

Curaleaf Challenges Aurora Criticism, Defends Premium Takeover Offer

Curaleaf issues fact sheet to address ‘misleading’ statements from Aurora

Veru Plans Phase 2 Trial of Oral Sabizabulin in Daraxonrasib-Resistant Metastatic Pancreatic Cancer

Veru - to Advance Oral Sabizabulin for Metastatic Pancreatic Cancer Resistant to Daraxonrasib

THOMSON REUTERS

Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ Rasonque™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK4557/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK4557","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","market":"US","secType":"PLATE","nameCN":"Cannabis Concept","latestPrice":246.51486,"timestamp":1789502399999,"preClose":245.36949,"halted":0,"volume":22423500,"delay":0,"changeRate":0.004668,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":1.14537,"latestTime":"09-15 16:00:00 EDT","open":245.34848,"high":248.12657,"low":241.34058,"amount":374864793.04824,"amplitude":0.027656,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.484041,"peRate":92.485057,"turnoverRate":0.007544,"increases":2,"decrements":13,"flats":1,"marketCap":60726663616.5,"floatMarketCap":53633624146.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4557\",,,,,undefined,":{"symbol":"BK4557","high":248.12657,"amplitude":0.027656,"preClose":245.36949,"low":241.34058,"pbRate":"3.484041","latestPrice":246.51486,"volume":22423500,"delay":0,"open":245.34848,"prevYearClose":226.48174,"prevWeekClose":244.1018,"prevMonthClose":240.6692,"prevQuarterClose":235.9952,"fiveDayClose":243.1504,"twentyDayClose":242.3446,"sixtyDayClose":220.1526,"secType":"PLATE","market":"US","turnoverRate":0.007544,"peRate":92.485057,"marketCap":60726663616.5,"floatMarketCap":53633624146.5,"timestamp":1789502399999,"nameCN":"Cannabis Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4557\",,,,undefined,":{"bkCode":"BK4557","up":2,"down":13,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4557\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666560015","title":"Shock Top and Auntie Anne’s® Take Over Tailgate Season with the Return of Shock Top Twisted Pretzel Wheat and the Limited-Edition TWIST Vest","url":"https://stock-news.laohu8.com/highlight/detail?id=2666560015","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666560015?lang=en_us&edition=fundamental","pubTime":"2026-09-10 19:00","pubTimestamp":1789038000,"startTime":"0","endTime":"0","summary":"“Beer Kneads Pretzels” Returns for Year Two with the Two-Way Insulated Snack Tailgater, a Buy-One-Get-One Pretzel Offer, an Atlanta Gameday Activation and an All-New Tailgate Content Series ATLANTA, S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359344/0/en/shock-top-and-auntie-anne-s-take-over-tailgate-season-with-the-return-of-shock-top-twisted-pretzel-wheat-and-the-limited-edition-twist-vest.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4547","BK4007","TLRY","BK4596","BK4557","SOCL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666627275","title":"Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2666627275","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666627275?lang=en_us&edition=fundamental","pubTime":"2026-09-10 18:04","pubTimestamp":1789034640,"startTime":"0","endTime":"0","summary":"TEL AVIV, Israel, Sept.  10, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) (“Teva”) announced today that it successfully priced its offering of approximately $4.9 ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/10/3359281/0/en/teva-announces-successful-pricing-of-4-9-billion-equivalent-senior-notes.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1983299246.USD","BK4584","BK4156","BK4007","BK4596","TEVA","BK4566","BK4585","BK4557","LU2324357040.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666946557","title":"Table: Aurora Corp Aug Rev Nt$950.6m vs Nt$917.5m","url":"https://stock-news.laohu8.com/highlight/detail?id=2666946557","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666946557?lang=en_us&edition=fundamental","pubTime":"2026-09-10 13:37","pubTimestamp":1789018620,"startTime":"0","endTime":"0","summary":"Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ACB","BK4007","MSOS","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666453568","title":"AIM ImmunoTech Advances Phase 2 Duripanc Trial of Ampligen Plus AstraZeneca’s Imfinzi in Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2666453568","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666453568?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:09","pubTimestamp":1788959353,"startTime":"0","endTime":"0","summary":"AIM ImmunoTech advances Phase 2 DURIPANC trial of Ampligen plus AstraZeneca’s Imfinzi in pancreatic cancerAIM ImmunoTech highlighted its ongoing Phase 2 DURIPANC trial testing Ampligen with AstraZenec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL9GcW4P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","NDAQ","IE00B64PRP62.GBP","BK4588","LU2095319765.USD","SG9999014005.SGD","BK4585","LU0314104364.USD","IE00BQXX3D17.EUR","LU2210149790.SGD","BK4112","IE00BQXX3F31.USD","IE00BN0W2T93.GBP","SG9999014039.USD","IE00BQXX3C00.GBP","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4557","SG9999014013.SGD","SG9999014021.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","BK4139","IE00BKPKM429.USD","BCDF","AIM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666580732","title":"Leerink Partners Initiates Coverage on Harrow With Outperform Rating, $45 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2666580732","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666580732?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:52","pubTimestamp":1788954767,"startTime":"0","endTime":"0","summary":"Harrow (HROW) has an average rating of buy and mean price target of $68.38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4557","BK4007","HROW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666659587","title":"Press Release: Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2666659587","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666659587?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:05","pubTimestamp":1788951900,"startTime":"0","endTime":"0","summary":"EDMONTON, AB, Sept. 9, 2026 /PRNewswire/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces Faris El Refaie, a biopharmaceutical le","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","03160","TM","ACB","BK4099","CNBS","BK4555","MSOX","BK4604","YOLO","BK4557","WEED","BK4232","R","MJ","MSOS","BK4588","BK4022","BK4007","TOKE","DBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666587656","title":"Press Release: Aurora Appoints Seasoned Biopharmaceutical Executive to Lead Commercial Acceleration of Global Medical Cannabis Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2666587656","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666587656?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:05","pubTimestamp":1788951900,"startTime":"0","endTime":"0","summary":"EDMONTON, AB, Sept. 9, 2026 /CNW/ -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces Faris El Refaie, a biopharmaceutical leader wi","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["YOLO","ACB","03160","BK4099","TM","MSOS","BK4557","BK4022","BK4585","DBB","BK4555","BK4588","WEED","MSOX","BK4604","BK4232","R","BK4007","TOKE","CNBS","MJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666879465","title":"Broncos Country, This One’s for You: Breckenridge Distillery Kicks Off Another Season with the Denver Broncos and a Limited-Edition Whiskey Collection Honoring “The Drive”","url":"https://stock-news.laohu8.com/highlight/detail?id=2666879465","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666879465?lang=en_us&edition=fundamental","pubTime":"2026-09-09 19:00","pubTimestamp":1788951600,"startTime":"0","endTime":"0","summary":"Celebrating six seasons as a proud whiskey partner of the Denver Broncos, Breckenridge Distillery debuts a limited-edition Bourbon Whiskey lineup and Creamsicle Whiskey Seltzer built for Broncos Count","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358460/0/en/broncos-country-this-one-s-for-you-breckenridge-distillery-kicks-off-another-season-with-the-denver-broncos-and-a-limited-edition-whiskey-collection-honoring-the-drive.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TLRY","BK4547","BK4596","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666582897","title":"Dr. Reddy's Laboratories Slides Wednesday, Still Outperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582897","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582897?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:31","pubTimestamp":1788949860,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Dr. Reddy's Laboratories Ltd.  shares inched down 0.72% to 1,143.20 Indian rupees Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the BSE SENSEX Index  falling 1.08% to 74,764.23.Dr. Reddy's Laboratories Ltd. closed 19.17% short of its 52-week high of 1,414.40 rupees, which the company reached on June 29th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Lupin Ltd.  fell 0.22% and Zydus Lifesciences Ltd.  fell 1.58%. Wockhardt Ltd.  rose 1.12%.Trading volume totaled 24,905, compared to the 50-day average of 109,134.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348744763.USD","BK4596","BK4007","BK4532","BK4557","RDY","BK4523"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584165","title":"Teva initiated with an Outperform at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584165","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584165?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:11","pubTimestamp":1788948675,"startTime":"0","endTime":"0","summary":"Leerink initiated coverage of Teva (TEVA) with an Outperform rating and $45 price target Published first on TheFly – the ultimate source for real-t...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/teva-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/teva-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TEVA","BK4559","BK4584","BK4596","BK4585","BK4588","BK4566","BK4007","LU1983299246.USD","BK4557","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666584451","title":"Harrow initiated with an Outperform at Leerink","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584451","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584451?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:10","pubTimestamp":1788948636,"startTime":"0","endTime":"0","summary":"Leerink initiated coverage of Harrow (HROW) with an Outperform rating and $45 price target Published first on TheFly – the ultimate source for real...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/harrow-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/harrow-initiated-with-an-outperform-at-leerink-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","HROW","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666723443","title":"SNDL Sets October 15 Virtual Meeting and Seeks Approval for Share Consolidation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666723443","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666723443?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:58","pubTimestamp":1788893887,"startTime":"0","endTime":"0","summary":"The latest announcement is out from SNDL ( ($SNDL) ). SNDL Inc. has filed a Form 6-K for September 2026, confirming the inclusion of its September ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sndl-sets-october-15-virtual-meeting-and-seeks-approval-for-share-consolidation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sndl-sets-october-15-virtual-meeting-and-seeks-approval-for-share-consolidation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","BK4547","MJ","SNDL","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666740933","title":"SNDL Sets Virtual Annual and Special Shareholder Meeting, Share Consolidation Vote on Agenda","url":"https://stock-news.laohu8.com/highlight/detail?id=2666740933","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666740933?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:38","pubTimestamp":1788892720,"startTime":"0","endTime":"0","summary":"SNDL sets virtual annual and special shareholder meeting, share consolidation vote on agendaSNDL will hold its annual and special shareholder meeting on Oct. 15, 2026 at 10:00 a.m. Toronto time.Ballot","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL5gfqxj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MJ","SNDL","BK4547","BK4557","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666096374","title":"SNDL Announces Annual and Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666096374","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666096374?lang=en_us&edition=fundamental","pubTime":"2026-09-09 02:38","pubTimestamp":1788892712,"startTime":"0","endTime":"0","summary":"SNDL announces annual and special shareholder meetingSNDL will hold its annual and special shareholder meeting virtually on October 15, 2026.Items include receiving audited financial statements for th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL4BNgtp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MJ","BK4547","BK4557","BK4007","SNDL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666837179","title":"Cannabis Poland Raises Capital Through New Share Issue and Warrant Allocation to CPAR","url":"https://stock-news.laohu8.com/highlight/detail?id=2666837179","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666837179?lang=en_us&edition=fundamental","pubTime":"2026-09-09 00:47","pubTimestamp":1788886076,"startTime":"0","endTime":"0","summary":"Cannabis Poland SA ( ($PL:CBD) ) just unveiled an update. Cannabis Poland S.A. has received a subscription from CPAR Ltd. for 11,903,882 series I s...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cannabis-poland-raises-capital-through-new-share-issue-and-warrant-allocation-to-cpar?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cannabis-poland-raises-capital-through-new-share-issue-and-warrant-allocation-to-cpar?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MJ","CNBS","MSOX","YOLO","WEED","BK4007","BK4557","MSOS","ACB","TOKE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665037667","title":"Curaleaf Challenges Aurora Criticism, Defends Premium Takeover Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665037667","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665037667?lang=en_us&edition=fundamental","pubTime":"2026-09-08 22:04","pubTimestamp":1788876273,"startTime":"0","endTime":"0","summary":"Curaleaf Holdings ( ($TSE:CURA) ) has provided an update. Curaleaf Holdings has published a fact sheet challenging what it calls misleading stateme...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/curaleaf-challenges-aurora-criticism-defends-premium-takeover-offer?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/curaleaf-challenges-aurora-criticism-defends-premium-takeover-offer?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4557","ACB","MSOS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665375057","title":"Curaleaf issues fact sheet to address ‘misleading’ statements from Aurora","url":"https://stock-news.laohu8.com/highlight/detail?id=2665375057","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665375057?lang=en_us&edition=fundamental","pubTime":"2026-09-08 21:41","pubTimestamp":1788874865,"startTime":"0","endTime":"0","summary":"Curaleaf Holdings (CURLF) released a fact sheet addressing a number of “inaccurate and misleading statements” made by Aurora Cannabis (ACB) in conn...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/curaleaf-issues-fact-sheet-to-address-misleading-statements-from-aurora-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/curaleaf-issues-fact-sheet-to-address-misleading-statements-from-aurora-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOKE","WEED","YOLO","CURLF","MSOS","MJ","BK4007","MSOX","BK4557","ACB","CNBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665320219","title":"Veru Plans Phase 2 Trial of Oral Sabizabulin in Daraxonrasib-Resistant Metastatic Pancreatic Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2665320219","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665320219?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869844,"startTime":"0","endTime":"0","summary":"Veru plans Phase 2 trial of oral sabizabulin in daraxonrasib-resistant metastatic pancreatic cancerVeru will advance oral sabizabulin into a planned Phase 2 trial for metastatic KRAS-driven pancreatic","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLlxV4k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4183","LU2095319765.USD","BK4584","SG9999014013.SGD","IE00BQXX3C00.GBP","IE00BN0W2T93.GBP","IE00BGHQF748.EUR","IE00BN0W2V16.EUR","LU2210150020.SGD","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014021.USD","BK4585","BK4007","VERU","BCDF","NDAQ","BK4557","IE00BKPKM429.USD","IE00BQXX3F31.USD","BK4588","SG9999014005.SGD","IE00B3QW5Z07.USD","LU0314104364.USD","IE00B64PRP62.GBP","SG9999014039.USD","IE00BQXX3D17.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665296320","title":"Veru - to Advance Oral Sabizabulin for Metastatic Pancreatic Cancer Resistant to Daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=2665296320","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665296320?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869820,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUAL04RT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4007","BK4557","VERU","BK4183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665202933","title":"Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ Rasonque™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665202933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665202933?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869820,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUAL04RT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VERU","BK4007","BK4183","BK4584","BK4557"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":89,"code":"91000000","status":"200"}]}}